JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY is an esteemed publication dedicated to the fields of Immunology and Allergy, published by ESMON PUBLICIDAD S A in collaboration with the Department of Allergy and Clinical Immunology at the University Clinical Navarra, Spain. With its rich history spanning over three decades since its inception in 1991, this journal has gained prominence in the scientific community, holding a commendable Q2 quartile in Allergy and a Q3 quartile in Immunology. Ranked within the top tiers of its categories according to Scopus, it stands at Rank #80/233 in Immunology and Allergy, and Rank #96/236 in Immunology and Microbiology, indicating its influential role in disseminating cutting-edge research and clinical insights. Though primarily print-focused, the journal strives to bridge gaps in knowledge and contribute to the ongoing dialogue among researchers, professionals, and students in the immunological sciences. The JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY is essential for anyone committed to advancing the understanding of allergic and immunological conditions.

Asia Pacific Allergy, published by Lippincott Williams & Wilkins, is a prominent academic journal dedicated to advancing research and clinical practice in the fields of dermatology, immunology, and allergy. With its ISSN 2233-8276 and E-ISSN 2233-8268, the journal provides a platform for innovative studies and reviews that cater to an international audience of researchers, healthcare professionals, and students involved in allergy and related disorders. Although it does not currently offer open access to its publications, the journal's robust output from 2015 to 2017 and its ongoing contribution to the literature from 2021 to 2024 showcase the evolving landscape of allergy research in the Asia Pacific region. Recognized in the 2023 Journal Citation Reports, it holds a Q2 ranking in Dermatology and a Q3 ranking in Immunology and Allergy, while its Scopus ranks further emphasize its significance within these domains, positioning it among the top journals in the field. As a source of cutting-edge research, Asia Pacific Allergy plays a vital role in fostering collaboration and knowledge dissemination, ultimately assisting in the betterment of patient care and treatment strategies across the region.

Dermatology Practical & Conceptual is a prominent open-access journal dedicated to advancing the field of dermatology through the dissemination of cutting-edge research and practical insights. Published by MATTIOLI 1885, this peer-reviewed journal has been committed to open access since 2015, ensuring that valuable information is readily available to researchers, healthcare professionals, and students worldwide. With a focus on innovative and practical approaches in dermatology, as well as its intersections with genetics, molecular biology, and oncology, the journal has established a strong academic presence, achieving a Q2 ranking in Dermatology and notable positions in related fields for 2023. Although its Scopus rankings indicate room for improvement in certain areas, such as genetics and molecular biology, the journal's commitment to quality and accessibility is evident in its engagement with contemporary research trends. The editors invite submissions that address practical challenges and novel methodologies, fostering a multidisciplinary dialogue that enhances dermatological practice and research. The journal operates from its base in Fidenza, Italy, and as it looks toward converged years from 2019 to 2024, it aims to further strengthen its influence and contribute significantly to the dermatological landscape.

Dermatitis, published by MARY ANN LIEBERT, INC, is a leading journal that focuses on the study of skin inflammation and allergic reactions, making significant contributions to the fields of Dermatology, Immunology, and Allergy. With an ISSN of 1710-3568 and an E-ISSN of 2162-5220, this peer-reviewed journal serves as a critical platform for researchers, healthcare professionals, and students alike, eager to share and explore groundbreaking findings and developments. Recognized for its impact and rigorous scholarly standards, Dermatitis has achieved a Q2 quartile ranking in dermatology and a Q3 ranking in immunology and allergy as of 2023, underscoring its significance in these vital medical sectors. The journal's Scopus ranking places it in the 84th percentile for dermatology and the 50th percentile for immunology and allergy, reflecting its wide acceptance and influence. With a scope spanning from 2004 to 2024, Dermatitis invites original research, reviews, and clinical updates that advance the understanding of skin disorders and therapy innovations, solidifying its role as an essential resource in enhancing skin health worldwide.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY is a premier peer-reviewed journal published by Elsevier Science Inc, dedicated to advancing the fields of allergy, asthma, and immunology. With its roots dating back to 1995 and with a focus on high-impact research, this journal has established itself as a leading platform for the dissemination of original research, reviews, and clinical studies within these critical areas. The journal boasts an impressive impact factor, supporting its Q2 ranking in both Immunology and Allergy, as well as in Pulmonary and Respiratory Medicine, indicating its significant contribution to the scientific community. Although it does not currently offer open access options, its comprehensive coverage and rigorous peer-review process ensure that published articles are of the highest quality, making it an invaluable resource for researchers, clinicians, and students alike. The Scopus rankings reflect its esteemed position in the academic landscape, providing professionals with access to cutting-edge developments and insights into the management and treatment of allergic and respiratory conditions.

Dermatologic Therapy is a leading peer-reviewed journal published by WILEY-HINDAWI that focuses on the multifaceted field of dermatology. Established in 1996 and continuing its profound impact into 2024, the journal has earned an impressive Q1 rating in Dermatology and ranks 11th out of 142 in the Scopus categorization, placing it in the 92nd percentile. With its headquarters in the United Kingdom, the journal's mission is to advance the understanding and treatment of skin diseases through the dissemination of high-quality research, reviews, and clinical information. Although not an open-access journal, it provides extensive access options to ensure that vital research reaches its audience. By leading scholarly discourse and innovation in dermatological treatments, Dermatologic Therapy serves as an essential resource for researchers, clinicians, and students dedicated to improving skin health worldwide.

Turkderm - Turkish Archives of Dermatology and Venerology, published by GALENOS PUBL HOUSE, serves as a vital platform for the dissemination of innovative research and advancements in the fields of dermatology and venerology. With an Open Access policy implemented since 2002, this journal aims to provide free and unrestricted access to significant findings, ensuring that vital information reaches a global audience. Based in Turkey, the journal has positioned itself as an important resource for professionals, researchers, and students alike, despite currently being categorized in Q4 of both Dermatology and Infectious Diseases as per the 2023 metrics. Although it faces competition in the rankings, with a Scopus standing of #131 in Dermatology and #331 in Infectious Diseases, its dedication to advancing knowledge in these critical health areas is unwavering. The journal continually invites original research, reviews, and case studies that enhance clinical practices and foster understanding in the dermatological community.

Annals of Dermatology is a prestigious academic journal published by the Korean Dermatological Association, focusing on the latest research and advancements in the field of dermatology. With a commitment to advancing knowledge in skin health and disease, this journal serves as a vital resource for researchers, clinicians, and students working in dermatology and related disciplines. Since its inception in 1989, it has evolved to consolidate its position in the academic community, boasting a Q2 ranking in the 2023 Dermatology category and a Scopus rank of #87 out of 142, placing it in the 39th percentile. Although it operates under a subscription model, the journal's impact factor reflects its significance in advancing dermatological research, attracting innovative studies and reviews that shape clinical practice. With a publication history extending from 1989 to 1996 and then from 2008 to the present, Annals of Dermatology continues to be an essential publication for those devoted to improving skin health.

ALLERGY is a leading international journal published by WILEY, dedicated to advancing the understanding of allergic diseases and immunology. With an ISSN of 0105-4538 and an E-ISSN of 1398-9995, this esteemed journal has been at the forefront of the field since its inception in 1948 and continues to publish high-quality research up until 2024. Positioned in the Q1 category for both Immunology and Allergy, ALLERGY ranks impressively within the top percentiles of its categories, underscoring its significant impact, as reflected in its Scopus rankings (#11 out of 233 in Immunology and Allergy, and #14 out of 236 in Immunology and Microbiology). Researchers and practitioners accessing this journal can expect a rigorous selection of peer-reviewed articles that address current challenges, innovative therapies, and advancements in the immunological sciences. Although it is not an open-access journal, ALLERGY remains vital for academics, healthcare professionals, and students alike, fostering a deeper understanding of the mechanisms and treatments associated with allergies.

Current Opinion in Allergy and Clinical Immunology, published by Lippincott Williams & Wilkins, is a pivotal journal that serves as a key resource for professionals in the fields of immunology and allergy. With an ISSN of 1528-4050 and an E-ISSN of 1473-6322, this journal presents cutting-edge reviews of the latest research findings, methodologies, and therapeutic approaches in the management of allergic and immunological disorders. With a Q3 category ranking in both Immunology and Allergy for 2023, and a Scopus rank of #103 in Immunology and Allergy, it reflects a solid position within the scientific community. Operating in the highly dynamic fields of immunology and clinical practice since its inception in 2001, the journal aims to harmonize emerging research trends with clinical applications to enhance patient outcomes. Although it does not currently offer Open Access options, the journal's substantial impact factor attests to its significance as a scholarly resource. By disseminating high-quality reviews and expert opinions, Current Opinion in Allergy and Clinical Immunology continues to foster knowledge advancement and professional development among researchers, practitioners, and students alike.